Product image of Letrozolo Sandoz (Letrozole) supplied by GNH India

Letrozolo Sandoz

Active Ingredient:
Letrozole
Origin:
EU

Letrozolo Sandoz (Letrozole)

Letrozole, the active ingredient in Letrozolo Sandoz, is an aromatase inhibitor presented as an oral tablet for oral use. It is employed in the treatment of hormone receptor‑positive breast cancer in postmenopausal women, where it reduces estrogen production that can fuel tumor growth.

GNH India supplies Letrozolo Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution through its dedicated regulatory team.

Manufacturer / TM Owner

Sandoz S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Letrozolo Sandoz, an aromatase inhibitor, is indicated for hormone‑dependent breast cancer.

  • Hormone receptor‑positive breast cancer (postmenopausal): Reduces estrogen levels to inhibit tumor growth.
  • Early‑stage hormone receptor‑positive breast cancer (adjuvant): Decreases risk of disease recurrence after surgery.
  • Metastatic hormone receptor‑positive breast cancer: Delays disease progression in advanced disease.

How It Works

  • Letrozole acts as a reversible inhibitor of the aromatase enzyme, which converts androgens to estrogens in peripheral tissues. By binding to the enzyme’s active site, it blocks estrogen synthesis, leading to markedly lower circulating estradiol concentrations. The resulting hypo‑estrogenic state limits the proliferative stimulus that estrogen‑dependent breast cancer cells require for growth.

Side Effects

Letrozolo Sandoz may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Hot flashes: Sudden feeling of warmth, often with sweating.
  • Joint and muscle pain: Arthralgia or myalgia.
  • Fatigue: Generalized tiredness.
  • Nausea: Mild to moderate upset stomach.
  • Headache: Tension‑type or migraine‑like pain.
  • Increased cholesterol: Elevated LDL levels.

Serious or Rare Side Effects

  • Osteoporosis or bone fractures: Decreased bone mineral density.
  • Severe liver injury: Elevated transaminases or hepatitis.
  • Cardiovascular events: Thromboembolic episodes.
  • Allergic reactions: Rash, pruritus, or anaphylaxis.
  • Hyperglycemia: Elevated blood glucose levels.

Precautions & Warnings

When prescribing Letrozolo Sandoz, clinicians should consider several precautionary measures to minimise risk.

  • Assess bone health: Perform baseline densitometry and monitor for osteoporosis.
  • Monitor lipid profile: Check cholesterol levels periodically.
  • Evaluate liver function: Conduct baseline and periodic liver enzyme tests.
  • Consider cardiovascular risk: Review history of thromboembolic disease.
  • Counsel on menopausal symptoms: Discuss management of hot flashes and sweating.
  • Store at ambient temperature: Keep below 25 °C in the original container, protect from moisture.

Avoid Interactions

Letrozolo Sandoz can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): May markedly reduce letrozole plasma levels.
  • Estrogen‑containing hormone therapy: Counteracts the drug’s estrogen‑lowering effect.

Moderate Interactions (Monitor Closely)

  • CYP2A6 inhibitors (e.g., fluvoxamine): May increase letrozole exposure.
  • Anticoagulants (warfarin): Potential for altered INR, requiring monitoring.
  • Cholesterol‑lowering agents (statins): May have additive effects on liver enzymes.
  • Selective serotonin reuptake inhibitors (SSRIs): Possible impact on hot‑flash management.

Frequently Asked Questions

Letrozolo Sandoz contains letrozole, an aromatase inhibitor indicated for the treatment of hormone receptor‑positive breast cancer in postmenopausal women. It is used in both early‑stage (adjuvant) settings and in metastatic disease to lower estrogen levels that can stimulate tumor growth.

Letrozole works by reversibly binding to the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. Inhibiting this enzyme sharply reduces circulating estrogen, depriving estrogen‑dependent breast cancer cells of a key growth signal.

The specific dose of Letrozolo Sandoz is determined by the prescribing clinician based on the patient’s clinical condition, treatment setting, and individual factors. Healthcare professionals follow approved labeling and clinical guidelines when selecting the appropriate regimen.

Letrozolo Sandoz is classified as contraindicated in pregnancy because it can interfere with normal fetal development. It is also not recommended during breastfeeding, as it may pass into milk and affect the infant. Women of child‑bearing potential should use effective contraception while on therapy.

To order Letrozolo Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrozolo Sandoz (letrozole) is a third‑generation aromatase inhibitor with a long half‑life and potent estrogen suppression. Compared with earlier agents such as anastrozole, letrozole often provides slightly greater estrogen reduction, which can translate into improved disease control in certain patient populations, though individual response varies.

Letrozolo Sandoz tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture and direct sunlight to maintain stability throughout its shelf life.

Letrozolo Sandoz is taken orally, usually once daily, with or without food, as directed by the prescribing physician. Patients should swallow the tablet whole and follow any specific instructions regarding timing relative to other medications.

Serious risks include osteoporosis or bone fractures due to reduced estrogen, severe liver injury, cardiovascular events such as thromboembolism, and rare allergic reactions. Patients should be monitored regularly for bone density, liver function, lipid levels, and any signs of hypersensitivity.

Letrozolo Sandoz should not be used in premenopausal women, pregnant or nursing individuals, and patients with known hypersensitivity to letrozole or any excipients in the tablet. Caution is also advised for patients with severe liver impairment or uncontrolled cardiovascular disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Letrozole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT